Article in American journal of physiology. Lung cellular and molecular physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Matthew K McPeekMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0000-0001-7463-8531
John C GomezMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0000-0003-4274-8132
Jessica R MartinMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0000-0002-1145-2235
Marie Anne IannoneMass Cytometry Core, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0009-0002-1883-425X
Hong DangMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0000-0002-7305-4208
Claire M DoerschukMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0000-0003-2638-3321
Funding
Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
TRAINING IN RESPIRATORY AND ENVIRONMENTAL MEDICINET32HL007106 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOUCHER, RICHARD CHARLES, DOERSCHUK, CLAIRE M · 1985 to 2021
$7.3M
Trafficking and function of macrophage subpopulations within the lung microenvironment during pneumoniaR01HL145396 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DOERSCHUK, CLAIRE M · 2019 to 2022
$2.3M
Uncovering and understanding the many functions of ICAM-1 in the lungs during homeostasis and innate immune responsesR01HL171598 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Claire M Doerschuk · 2024 to 2026
$2.3M
HHS | NIH | National Cancer Institute (NCI) P30CA016086NCI NIH HHS P30 CA016086NHLBI NIH HHS R01 HL145396NHLBI NIH HHS R01 HL171598NHLBI NIH HHS T32 HL007106UNC | UNC-CH | School of Medicine, University of North Carolina at Chapel Hill (SOM) Office of Research Technologies
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Leukocyte kinetics and bacterial clearance during · full record | OpenQuestion